| + |
BTG2 | up-regulates quantity by expression 
transcriptional regulation
|
SOD1 |
0.2 |
| Identifier |
Residue |
Sequence |
Organism |
Cell Line |
| SIGNOR-254650 |
|
|
Homo sapiens |
MCF-7 Cell |
| pmid |
sentence |
| 22493435 |
BTG2 was found to up-regulate expression of antioxidant enzymes known to be regulated by NFE2L2, including catalase, SOD1, and SOD2 |
|
| Publications: |
1 |
Organism: |
Homo Sapiens |
| + |
BTG2 | up-regulates quantity by expression
transcriptional regulation
|
SOD2 |
0.378 |
| Identifier |
Residue |
Sequence |
Organism |
Cell Line |
| SIGNOR-254649 |
|
|
Homo sapiens |
MCF-7 Cell |
| pmid |
sentence |
| 22493435 |
BTG2 was found to up-regulate expression of antioxidant enzymes known to be regulated by NFE2L2, including catalase, SOD1, and SOD2 |
|
| Publications: |
1 |
Organism: |
Homo Sapiens |
| + |
BTG2 | down-regulates quantity by repression 
transcriptional regulation
|
KLK3 |
0.2 |
| Identifier |
Residue |
Sequence |
Organism |
Cell Line |
| SIGNOR-253658 |
|
|
|
|
| pmid |
sentence |
| 21172304 |
Androgen-induced promoter activation and expression of prostate-specific antigen (PSA) are significantly attenuated by BTG2. |
|
| Publications: |
1 |
| + |
BTG2 | up-regulates quantity by expression
transcriptional regulation
|
CAT |
0.2 |
| Identifier |
Residue |
Sequence |
Organism |
Cell Line |
| SIGNOR-254648 |
|
|
Homo sapiens |
MCF-7 Cell |
| pmid |
sentence |
| 22493435 |
BTG2 was found to up-regulate expression of antioxidant enzymes known to be regulated by NFE2L2, including catalase, SOD1, and SOD2 |
|
| Publications: |
1 |
Organism: |
Homo Sapiens |
| + |
BTG2 | up-regulates activity 
binding
|
NFE2L2 |
0.2 |
| Identifier |
Residue |
Sequence |
Organism |
Cell Line |
| SIGNOR-254647 |
|
|
Homo sapiens |
MCF-7 Cell |
| pmid |
sentence |
| 22493435 |
BTG2 stimulation of antioxidant gene expression is also NFE2L2-dependent. We further demonstrate that BTG2 is a binding partner for NFE2L2 and increases its transcriptional activity. |
|
| Publications: |
1 |
Organism: |
Homo Sapiens |
| + |
AR | down-regulates quantity by repression
transcriptional regulation
|
BTG2 |
0.385 |
| Identifier |
Residue |
Sequence |
Organism |
Cell Line |
| SIGNOR-253674 |
|
|
Homo sapiens |
LNCaP Cell |
| pmid |
sentence |
| 16281084 |
After AR antagonist flutamide treatment, three hundred and twenty-six genes (3.93%) expressed differentially, 97 down-regulated and 219 up-regulated. Among them, eight up-regulated genes might be cell cycle-related, namely CDC10, NRAS, BTG1, Wee1, CLK3, DKFZP564A122, CDKN1A and BTG2. The CDKN1A and BTG1 gene mRNA expression was confirmed to be higher in the experimental group by RT-PCR, while p53 mRNA expression had no significant changes. |
|
| Publications: |
1 |
Organism: |
Homo Sapiens |
| + |
BTG2 | up-regulates activity
binding
|
HOXB9 |
0.672 |
| Identifier |
Residue |
Sequence |
Organism |
Cell Line |
| SIGNOR-220987 |
|
|
Homo sapiens |
HeLa Cell |
| pmid |
sentence |
| 10617598 |
The leukemia-associated protein Btg1 and the p53-regulated protein Btg2 interact with the homeoprotein Hoxb9 and enhance its transcriptional activation. |
|
| Publications: |
1 |
Organism: |
Homo Sapiens |
3.0
BTG2
- 
- 